Veterinary Medicines

ACA CERULEN, gocce auricolari, per cani e gatti

Authorised
  • Dichlorophen
  • Piperonyl butoxide
  • 25% PYRETHRUM EXTRACT
Download as PDF

Product identification

Medicine name:
ACA CERULEN, gocce auricolari, per cani e gatti
Active substance:
  • Dichlorophen
  • Piperonyl butoxide
  • 25% PYRETHRUM EXTRACT
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Dichlorophen
    1.00
    gram(s)
    /
    100.00
    gram(s)
  • Piperonyl butoxide
    2.50
    gram(s)
    /
    100.00
    gram(s)
  • 25% PYRETHRUM EXTRACT
    1.00
    gram(s)
    /
    100.00
    gram(s)
Pharmaceutical form:
  • Ear drops, solution
Withdrawal period by route of administration:
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53A
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Teknofarma S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Teknofarma S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."